ArticleJournal of hepatocellular carcinoma2025

In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma.

Ja-Der Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.